3 results

News

Cepheid Inc. validates Copan eNAT® sample collection

Cepheid Inc. just validated the use of Copan eNAT® to collect nasal and nasopharyngeal samples to be analyzed with its Xpert Xpress CoV-2/Flu/RSV plus assay. The combination of these two best-in-class solutions will provide laboratories worldwide with improved efficiency and operators safety, granting patients the best clinical results.

Copan Group

Microbiology time

Microbiology Time – October 2021

October’s update of our scientific database is full of exciting papers. Among them, we selected a study on HPV-related cancer screening, a research on direct amplification of disaster victim identification samples, and a comparison of sample collection and transport methods to enhance yield and biosafety of COVID-19 testing.

Copan Group

Microbiology time

Microbiology Time – September 2021

We just updated our scientific studies database with numerous studies. This month’s top picks analyze SRK® sample stability, SARS-CoV-2 self-collection FLOQSwabs®, and antibiotic resistances in Belgian and Dutch farms.

Copan Group